Company News

Xi'an DELI Biochemical Industry Co., Ltd.: Leading Innovation in Cyclodextrin Derivatives, Empowering the Pharmaceutical Industry

2025-03-04

Xi'an, China - Xi'an DELI Biochemical Industry Co., Ltd., a high-tech enterprise specializing in the research, production, and sales of cyclodextrin derivatives, recently announced breakthrough progress in the application of its flagship products, Hydroxypropyl Beta-Cyclodextrin (HP-β-CD) and Sulfobutylether Beta-Cyclodextrin Sodium (SBE-β-CD), in the pharmaceutical field.


Deep Expertise in Cyclodextrin, Delivering High-Quality Products


Since its establishment, Xi'an DELI Biochemical Industry Co., Ltd. has been committed to the research and development of cyclodextrin derivatives. The company boasts an experienced R&D team and advanced production facilities, adhering strictly to international quality standards to ensure high purity, stability, and safety of its products.


HP-β-CD: Hydroxypropyl beta cyclodextrin Enhancing Solubility and Stability, Improving Drug Efficacy

Hydroxypropyl beta cyclodextrin (HP-β-CD) is one of the star products of Xi'an DELI Biochemical Industry Co., Ltd. As a water-soluble cyclodextrin derivative, Hydroxypropyl beta cyclodextrin exhibits excellent solubilization, stabilization, and taste-masking properties. It effectively improves the solubility and bioavailability of poorly soluble drugs, enhances drug stability, and improves taste, making it widely applicable in injectables, oral formulations, ophthalmic preparations, and more.


SBE-β-CD: Sulfobutyl Ether Beta Cyclodextrin Sodium Safe and Efficient, Advancing New Drug Development

Sulfobutyl Ether Beta Cyclodextrin Sodium (SBE-β-CD) is another highly regarded product from Xi'an DELI Biochemical Industry Co., Ltd. Compared to Hydroxypropyl beta cyclodextrin, Sulfobutyl Ether Beta Cyclodextrin Sodium offers lower hemolytic activity and higher safety, making it particularly suitable for drug formulations with stringent safety requirements, such as injectables. Additionally, Sulfobutyl Ether Beta Cyclodextrin Sodium can serve as a novel drug carrier for gene delivery, targeted drug delivery, and other cutting-edge fields, providing new ideas and solutions for new drug development.


About Xi'an DELI Biochemical Industry Co., Ltd.


Xi'an Deli Biochemical Industry Co.,Ltd. Is a high-tech enterprise specializing in research & development, production & sales of cyclodextrin and its derivatives.


Since its establishment on August 27, 1999,the company has been adhering to the quality Policy of "focusing on accessories, quality first, sincere service, striving for first-class". After more than 20 years of hard work and development, the company currently has products DELI Brand Hydroxypropyl beta cyclodextrin (HP-β-CD), DELI Brand Betadex Sulfobutyl Ether Sodium. The above products have been registered and filed with the FDA.


The company is located in Lintong District,Xi'an, covering an area of 17.8 mu, plant area of more than 1,000 square meters. According to the production process requirements, the company specially set up a D class clean area. Now has an annual output of 500 tons of Hydroxypropyl beta cyclodextrin (HP-β-CD), 200 tons of Sulfobutyl Ether Beta Cyclodextrin Sodium (SBE-β-CD) production line. The testing center of the company is equipped with Thermo ICS-6000SP ion chromatography, Beckman P/ACE MDQ PLUS capillary electrophoresis, Waters 2695 high performance liquid chromatography, Agilent 6890 gas chromatography,FTIR-650(high configuration) infrared spectrometer, WZ2-2B automatic polarimeter, automatic moisture tester and other more than 20 testing equipments (sets), can meet the testing needs of each production link of products. The company's management system has passed lSO 9001:2015 certification.


Xi'an DELI Biochemical Industry Co., Ltd. remains committed to innovation-driven development, continuously increasing R&D investment, and actively expanding the application fields of cyclodextrin derivatives. The company has established long-term, stable partnerships with numerous renowned pharmaceutical companies and research institutions worldwide, jointly promoting the application and development of cyclodextrin derivatives in the pharmaceutical industry.


Looking ahead, Xi'an DELI Biochemical Industry Co., Ltd. will continue to uphold its business philosophy of "Quality First, Customer Foremost," delivering high-quality products and services to contribute to the global pharmaceutical industry.


X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept